Within a latest study, we claimed the identification plus the characterization of a completely new atypical opioid receptor with distinctive adverse regulatory Homes towards opioid peptides.1 Our results confirmed that ACKR3/CXCR7, hitherto known as an atypical scavenger receptor for chemokines CXCL12 and CXCL11, is also a broad-spectrum scavenger